Nothing Special   »   [go: up one dir, main page]

De Gascun et al., 2013 - Google Patents

Human polyomavirus reactivation: disease pathogenesis and treatment approaches

De Gascun et al., 2013

View PDF @Full View
Document ID
17603739958214316137
Author
De Gascun C
Carr M
Publication year
Publication venue
Journal of Immunology Research

External Links

Snippet

JC and BK polyomaviruses were discovered over 40 years ago and have become increasingly prevalent causes of morbidity and mortality in a variety of distinct, immunocompromised patient cohorts. The recent discoveries of eight new members of the …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Similar Documents

Publication Publication Date Title
De Gascun et al. Human polyomavirus reactivation: disease pathogenesis and treatment approaches
Cortese et al. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
Major et al. Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
Ferenczy et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
Lucas et al. Epstein–Barr virus and multiple sclerosis
Ambalathingal et al. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies
Faizan et al. Zika virus-induced microcephaly and its possible molecular mechanism
Hirsch et al. The human JC polyomavirus (JCPyV): virological background and clinical implications
Assetta et al. The biology of JC polyomavirus
Sturdevant et al. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection
Schultheiss et al. Viral myocarditis—from pathophysiology to treatment
Weissert Progressive multifocal leukoencephalopathy
Bihari et al. Parvovirus B19 associated hepatitis
Tavazzi et al. Progressive multifocal leukoencephalopathy: clinical and molecular aspects
Li et al. Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection
Ruprecht The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review
Wenderfer Viral-associated glomerulopathies in children
Li et al. Peripheral T lymphocyte subset imbalances in children with enterovirus 71-induced hand, foot and mouth disease
Beltrami et al. Immune surveillance and response to JC virus infection and PML
Lin et al. Advances in hepatitis E virus biology and pathogenesis
Reuwer et al. The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy
Rahbar et al. Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV
Xu et al. Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate
Gaspar-Rodríguez et al. Coronavirus persistence in human respiratory tract and cell culture: An overview
Tsatsralt-Od et al. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia